Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-Associated Steatotic Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT06138327
What this trial is testing

BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria

Who this might be right for
HyperoxaluriaNonalcoholic Fatty Liver DiseaseKidney Stone
BioMarin Pharmaceutical
Large-scale testing (Phase 3)UnknownNCT06759363
What this trial is testing

MASLD Butyrate Supplementation Treatment Efficacy Review

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University Medical Center Zvezdara 200
Not applicableLooking for participantsNCT07192159
What this trial is testing

Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatic SteatosisLiver Disease Parenchymal
Seoul National University Hospital 62
Not applicableNot Yet RecruitingNCT06694974
What this trial is testing

Liver Fibrosis Assessment in Diabetic Patients

Who this might be right for
Type 2 DiabetesMetabolic Dysfunction-Associated Steatotic Liver Disease
National Taiwan University Hospital 540
Not applicableUnknownNCT06359444
What this trial is testing

Effect of High Intensity Exercise Rehabilitation on Liver Function and Insulin Sensitivity in Patients With MASLD

Who this might be right for
Exercise TherapyMetabolic Dysfunction-associated Steatotic Liver Disease
University Ghent 92
Not applicableStudy completedNCT05804955
What this trial is testing

Alpha-Glutathione-S-Transferase (AlphaGST) and MARINA Index in Metabolic-Dysfunction-Associated-Steatotic-Liver-Disease (MASLD)

Who this might be right for
Fatty Liver
University of Campania Luigi Vanvitelli 260
Not applicableEnrolling By InvitationNCT06703450
What this trial is testing

Guerbet Liver Fibrosis

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Icahn School of Medicine at Mount Sinai 50
Not applicableEnrolling By InvitationNCT07199491
What this trial is testing

Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic-dysfunction Associated Liver Disease (MASLD)
The University of Texas Health Science Center, Houston 64
Not applicableNot Yet RecruitingNCT07764835
What this trial is testing

Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis B+2 more
D'Or Institute for Research and Education 300
Not applicableLooking for participantsNCT07122700
What this trial is testing

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver DiseaseMetabolic Associated Steatotic Liver DiseaseCirrhosis, Liver+5 more
Foundation for the National Institutes of Health 400
Not applicableUnknownNCT06403332
What this trial is testing

Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.

Who this might be right for
Alcohol-related Liver DiseaseAlcohol Use DisorderMetabolic and Alcohol Related/Associated Liver Disease+1 more
Hospital Universitari Vall d'Hebron Research Institute 350
Not applicableStudy completedNCT06121999
What this trial is testing

Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults

Who this might be right for
Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)Metabolic Associated-dysfunction Steatohepatitis (MASH)
Grand Valley State University 24
Not applicableLooking for participantsNCT07530809
What this trial is testing

Time-restricted Feeding in MASLD

Who this might be right for
Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)
Universität des Saarlandes 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623044
What this trial is testing

Effects of Short-term Perioperative Daidzein Intervention on Liver Histopathology in Patients With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eastern Hepatobiliary Surgery Hospital 44
Not applicableStudy completedNCT07566299
What this trial is testing

Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Obesity Type 2 Diabetes MellitusCardiovascular-kidney-metabolic SyndromeMetabolic Dysfunction-Associated Steatotic Liver Disease
Chung Shan Medical University 118,805
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Not applicableLooking for participantsNCT06506513
What this trial is testing

Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 60
Testing effectiveness (Phase 2)Study completedNCT06465186
What this trial is testing

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisNAFLD+2 more
Merck Sharp & Dohme LLC 85
Not applicableNot Yet RecruitingNCT07475962
What this trial is testing

Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesLiver SteatosesMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
Institut de Recherches Cliniques de Montreal 100
Next Page
15